Competition Policy and Pharmaceutical Markets

Zoom (no registration): go.rutgers.edu/comppolicypharma

9:15 - 10:30 am

• Doni Bloomfield, Fordham Law School—The Law and Economics of Resilience
• Robin Feldman, UC School of Law SF—Pipeline Divestitures in the Pharmaceutical Sector
• Christopher Leslie, UC Irvine School of Law—Rebate Walls: Formulary Exclusion of Generic Drugs

10:45 am - 12:00 pm

• Mike Carrier, Rutgers Law School—PBMs: The Hidden Actor Behind Product Hopping
• Mark Lemley, Stanford Law School—Treating Equivalents as Equivalent: A Simple Fix for the Product Hopping Problem
• Ameet Sarpatwari, Harvard Medical School—Preventing the Misuse of Risk Evaluation and Mitigation Strategies

1:00 - 2:15 pm

• Arti Rai, Duke Law School—Biologics Competition, Branded and Biosimilar
• Rachel E. Sachs, Washington University School of Law—A New Framework for Drug Pricing Law and Policy
• Sean Tu, West Virginia University College of Law—Differential Legal Protections for Biologics vs Small-Molecule Drugs in the US

2:30 - 3:45 pm, Enforcers’ Roundtable

• Elizabeth Arthur, Assistant Attorney General, District of Columbia Office of the Attorney General
• Gwendolyn Cooley, Former Assistant Attorney General for Antitrust, State of Wisconsin
• Victoria Field, Assistant Attorney General, Office of the Attorney General Connecticut